Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1968 Jul;3(6):555–569.

Studies into the occurrence of soluble antigen–antibody complexes in disease. III. Rheumatoid arthritis and other human diseases

R Baumal, I Broder
PMCID: PMC1578954  PMID: 4178232

Abstract

We have found that a histamine-releasing agent, designated the rheumatoid biologically active factor (RBAF), was commonly detected in the Sephadex excluded fraction of serum and of synovial fluid obtained from patients with rheumatoid arthritis. A similar agent was also found in anaphylactoid purpura and in systemic lupus erythematosus, but not in patients with a variety of other diseases or in healthy persons. The RBAF closely resembled a soluble antigen–antibody complex, since it sedimented as a high molecular weight material and yet was specifically precipitated by goat anti-human γG-globulin. Also, the RBAF was insoluble at 50% saturation with ammonium sulphate, was stable to reduction and alkylation, underwent partial dissociation following gel filtration on Sephadex G-200 at pH 3·0, and did not stimulate the guinea-pig ileum. Moreover, the histamine-releasing activity of the RBAF was completely inhibited by human and rabbit γ-globulin. These features enabled the RBAF to be distinguished from human aggregated γ-globulin, from antibody to γ-globulin, and from anaphylatoxin, each of which also stimulated histamine release from the guinea-pig lung. The RBAF was shown to be different from both the the rheumatoid latex agglutinating factor and from the acid-dissociable γ-globulin aggregates present in the serum of some patients with rheumatoid arthritis.

Full text

PDF
555

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AHO K., SIMONS K. STUDIES OF THE ANTIBODY NATURE OF THE RHEUMATOID FACTOR. REACTION OF THE RHEUMATOID FACTOR WITH HUMAN SPECIFIC PRECIPITATES AND WITH NATIVE HUMAN GAMMA GLOBULIN. Arthritis Rheum. 1963 Dec;6:676–688. doi: 10.1002/art.1780060603. [DOI] [PubMed] [Google Scholar]
  2. Allen J. C., Kunkel H. G. Hidden rheumatoid factors with specificity for native gamma globulins. Arthritis Rheum. 1966 Dec;9(6):758–768. doi: 10.1002/art.1780090603. [DOI] [PubMed] [Google Scholar]
  3. BRODER I., SCHILD H. O. THE ACTION OF SOLUBLE ANTIGEN--ANTIBODY COMPLEXES IN PERFUSED GUINEA-PIG LUNG. Immunology. 1965 Mar;8:300–318. [PMC free article] [PubMed] [Google Scholar]
  4. BUTLER V. P., Jr, VAUGHAN J. H. THE REACTION OF RHEUMATOID FACTOR WITH ANIMAL GAMMA-GLOBULINS: QUANTITATIVE CONSIDERATIONS. Immunology. 1965 Feb;8:144–159. [PMC free article] [PubMed] [Google Scholar]
  5. Baumal R., Broder I. Studies into the occurrence of soluble antigen--antibody complexes in disease. I. A biological assay for soluble complexes. Clin Exp Immunol. 1968 Jul;3(6):525–536. [PMC free article] [PubMed] [Google Scholar]
  6. Broder I., Baumal R., Keystone E. Studies into the occurrence of soluble antigen-antibody complexes in disease. II. Criteria for distinguishing soluble complexes from other macromolecular histamine releasers. Clin Exp Immunol. 1968 Jul;3(6):537–553. [PMC free article] [PubMed] [Google Scholar]
  7. CHODIRKER W. B., TOMASI T. B., Jr Low-molecular-weight rheumatoid factor. J Clin Invest. 1963 Jun;42:876–884. doi: 10.1172/JCI104780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. DIXON F. J., FELDMAN J. D., VAZQUEZ J. J. Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J Exp Med. 1961 May 1;113:899–920. doi: 10.1084/jem.113.5.899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DIXON F. J. THE ROLE OF ANTIGEN-ANTIBODY COMPLEXES IN DISEASE. Harvey Lect. 1963;58:21–52. [PubMed] [Google Scholar]
  10. Dias Da Silva W., Lepow I. H. Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement. J Exp Med. 1967 May 1;125(5):921–946. doi: 10.1084/jem.125.5.921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. EDELMAN G. M., KUNKEL H. G., FRANKLIN E. C. Interaction of the rheumatoid factor with antigen-antibody complexes and aggregated gamma globulin. J Exp Med. 1958 Jul 1;108(1):105–120. doi: 10.1084/jem.108.1.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. FRICK O. L., LIACOPOULOS P., RAFFEL S. ANTIGEN EXCESS IN GUINEA PIG ANAPHYLAXIS. J Immunol. 1965 Jun;94:890–897. [PubMed] [Google Scholar]
  13. Hannestad K. Presence of aggregated gamma-G-globulin in certain rheumatoid synovial effusions. Clin Exp Immunol. 1967 Jul;2(4):511–529. [PMC free article] [PubMed] [Google Scholar]
  14. ISHIZAKA K., ISHIZAKA T., BANOVITZ J. BIOLOGIC ACTIVITY OF SOLUBLE ANTIGEN-ANTIBODY COMPLEXES. IX. SOLUBLE COMPLEXES OF RABBIT ANTIBODY WITH UNIVALENT AND DIVALENT HAPTENS. J Immunol. 1964 Dec;93:1001–1007. [PubMed] [Google Scholar]
  15. Ishizaka K., Ishizaka T., Hornbrook M. M. Physicochemical properties of reaginic antibody. V. Correlation of reaginic activity wth gamma-E-globulin antibody. J Immunol. 1966 Dec;97(6):840–853. [PubMed] [Google Scholar]
  16. Ishizaka T., Ishizaka K., Salmon S., Fudenberg H. Biologic activities of aggregated gamma-globulin. 8. Aggregated immunoglobulins of different classes. J Immunol. 1967 Jul;99(1):82–91. [PubMed] [Google Scholar]
  17. KUNKEL H. G., MULLER-EBERHARD H. J., FUDENBERG H. H., TOMASI T. B. Gamma globulin complexes in rheumatoid arthritis and certain other conditions. J Clin Invest. 1961 Jan;40:117–129. doi: 10.1172/JCI104224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. MCCLUSKEY R. T., BENACERRAF B., POTTER J. L., MILLER F. The pathologic effects of intravenously administered soluble antigen-antibody complexes. I. Passive serum sickness in mice. J Exp Med. 1960 Feb 1;111:181–194. doi: 10.1084/jem.111.2.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Michael A. F., Jr, Drummond K. N., Good R. A., Vernier R. L. Acute poststreptococcal glomerulonephritis: immune deposit disease. J Clin Invest. 1966 Feb;45(2):237–248. doi: 10.1172/JCI105336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Moskowitz R. W. Human serum necrotizing factor: basic properties and clinical significance. J Lab Clin Med. 1965 Dec;66(6):927–936. [PubMed] [Google Scholar]
  21. OVARY Z., FUDENBERG H., KUNKEL H. G. Anuphylactic reactions in the skin of the guinea pig with high and low molecular weight antibodies and gamma globulins. J Exp Med. 1960 Nov 1;112:953–961. doi: 10.1084/jem.112.5.953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. ROPES M. W., BENNETT G. A., COBB S., JACOX R., JESSAR R. A. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958 Dec;9(4):175–176. [PubMed] [Google Scholar]
  23. Tan E. M., Schur P. H., Carr R. I., Kunkel H. G. Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest. 1966 Nov;45(11):1732–1740. doi: 10.1172/JCI105479. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES